America’s overdose crisis isn’t the simple story we’ve been told for years. A new investigation reveals how two key graphs — ...

The FDA has granted accelerated approval to Otsuka’s Voyxact for adults with primary IgAN at risk of disease progression, ...

Gan & Lee Pharmaceuticals begins GRADUAL-3 phase 3 study of first Chinese once-monthly GLP-1 RA for weight management: Beijing, China Monday, December 1, 2025, 18:00 Hrs [IST] Gan ...

People at high risk of lung cancer will soon be able to receive the first ever experimental vaccine designed to prevent the ...

FLASH2 study Blinded Response Rate to Date Exceeds Trial Estimate PRINCETON, N.J., Nov. 19, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix ...

An experimental cancer vaccine developed at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for ...

Scientists speak out about the studies and patients affected by unprecedented federal funding cuts for research sponsored by ...

Alto Neuroscience, Inc.'s innovative approach to CNS disorder treatment and 2026 clinical milestones. Click here to find out why ANRO stock is a Buy.

ALL is the most common childhood cancer, and cases are rising. Find out why this trend is paired with a remarkable 90% survival rate, and what public health action is needed next.

Children with avoidant/restrictive food intake were significantly more likely than control individuals to have developmental ...

A new study highlights how important uninterrupted sleep is to recovery after a traumatic brain injury, finding that ...